12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Inovio preclinical data

In mice, Inovio's SynCon DNA HBV vaccine delivered with the company's electroporation system induced "strong" antigen-specific T cell and high titer antibody responses systemically and in the liver. Inovio...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >